Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
50.08
-2.35 (-4.48%)
At close: Oct 23, 2026, 4:00 PM EDT
50.08
0.00 (0.00%)
After-hours: Oct 23, 2026, 4:10 PM EDT
Travere Therapeutics Market Cap
Travere Therapeutics has a market cap or net worth of $4.72 billion as of October 23, 2026. It is the 3,610th most valuable company in the world and the 1,167th biggest in the United States. Its market cap has increased by 92.72% in one year.
Market Cap
4.72B
Enterprise Value
4.85B
1-Year Change
92.72%
Global Rank
Country Rank
#1,167 United States
Category
ChartMarket Cap Chart
Since December 31, 2012, Travere Therapeutics's market cap has increased from $40.40M to $4.72B, an increase of 11,584.64%. That is a compound annual growth rate of 41.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 4.72B | 38.08% |
| Dec 31, 2025 | 3.42B | 151.45% |
| Dec 31, 2024 | 1.36B | 101.24% |
| Dec 29, 2023 | 675.60M | -49.94% |
| Dec 30, 2022 | 1.35B | -28.99% |
| Dec 31, 2021 | 1.90B | 36.59% |
| Dec 31, 2020 | 1.39B | 128.10% |
| Dec 31, 2019 | 610.00M | -34.65% |
| Dec 31, 2018 | 933.40M | 12.70% |
| Dec 29, 2017 | 828.20M | 15.95% |
| Dec 30, 2016 | 714.30M | 2.44% |
| Dec 31, 2015 | 697.30M | 113.37% |
| Dec 31, 2014 | 326.80M | 153.92% |
| Dec 31, 2013 | 128.70M | 218.56% |
| Dec 31, 2012 | 40.40M | - |
| Dec 31, 2012 | 40.40M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.56B |
| Kodiak Sciences | 5.42B |
| Mirum Pharmaceuticals | 5.41B |
| Cogent Biosciences | 5.41B |
| Oruka Therapeutics | 5.35B |
| PTC Therapeutics | 5.26B |
| Scholar Rock Holding | 5.11B |
| Erasca | 4.87B |